IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,922 | -48.5% | 72,730 | -20.3% | 0.00% | -50.0% |
| Q2 2023 | $642,759 | -32.0% | 91,301 | -41.0% | 0.00% | -33.3% |
| Q1 2023 | $944,997 | +201.2% | 154,664 | +215.0% | 0.00% | +200.0% |
| Q4 2022 | $313,775 | +82.4% | 49,104 | +173.6% | 0.00% | 0.0% |
| Q3 2022 | $172,000 | -18.9% | 17,945 | -6.7% | 0.00% | 0.0% |
| Q2 2022 | $212,000 | -96.7% | 19,231 | -91.8% | 0.00% | -97.0% |
| Q2 2020 | $6,470,000 | +1111.6% | 235,704 | +1220.5% | 0.03% | +1000.0% |
| Q1 2020 | $534,000 | -39.5% | 17,850 | -44.1% | 0.00% | 0.0% |
| Q4 2019 | $883,000 | -41.1% | 31,918 | -61.2% | 0.00% | -50.0% |
| Q3 2019 | $1,498,000 | – | 82,283 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |